Diabetes News and Research

Latest Diabetes News and Research

Bio-Quant to be acquired by NexMed

NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has entered into a definitive agreement to acquire Bio-Quant, Inc., a revenue generating privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.

23 Nov 2009

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors.

23 Nov 2009

Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, and Handok Pharmaceuticals Co., Ltd., a fully integrated Korean pharmaceutical company, today announced a collaboration for the development and commercialization of apaziquone in South Korea. Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer by intravesical instillation.

23 Nov 2009

Amniotic fluid stem cells have potential to become specialized cell types, say researchers

For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.

23 Nov 2009

Study examines how dietary restriction and high-caloric diet influence biochemical responses

Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease?

23 Nov 2009

Pennsylvania Department of Health commences H1N1 vaccination to members of priority groups

The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine.

21 Nov 2009

Obesity: A major contributor to the development of Type 2 diabetes

"Many Americans have a very limited understanding of the basic facts about diabetes, as well as the serious consequences for health that accompany the disease," commented Sue McLaughlin, RD, CDE, President, Health Care & Education, American Diabetes Association, in a media alert. She blames the problem on a combination of factors including denial of the disease and promotion of inaccurate information or myths surrounding diabetes.

21 Nov 2009

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder.

21 Nov 2009

Employers take action to improve medication adherence

More employers are taking steps to improve their employees' health by making sure they take their medicines as prescribed, a move that could stave off more serious and costly health consequences, according to a new report sponsored by the National Pharmaceutical Council (NPC).

21 Nov 2009

PhRMA reaffirms its commitment to support the health reform

POLITICO recently published an editorial by Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson. In the editorial, Johnson makes the case for health reform and reaffirm's PhRMA's commitment to supporting this historic effort.

21 Nov 2009

ESC and EASD organize Joint Scientific Forum in China to address optimal treatment strategies for diabetes

As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most respected professional medical organisations in Europe, will be held from 27-29 November at three venues across China - Beijing, Shanghai and Guangzhou.

21 Nov 2009

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

20 Nov 2009

First-quarter fiscal 2010 results announced by Escalon Medical

Escalon Medical Corp. announced the results for its fiscal first quarter ended September 30, 2009.

20 Nov 2009

8.3% of households in Massachusetts struggle with food insecurity

Project Bread, the state's leading anti-hunger organization, released numbers from its upcoming annual status report on hunger in the Commonwealth. The disquieting trends described in this report, caused by high unemployment, point to 554,000 people in the Commonwealth struggling with hunger.

20 Nov 2009

Nutrisystem announces support for the Stop Diabetes movement

Nutrisystem, Inc., a leading developer of weight loss products and services, today announced its company-wide support for the recently launched Stop DiabetesSM movement from the American Diabetes Association. On the heels of the successful launch of Nutrisystem D, its program designed to help people with type 2 diabetes lose weight, Nutrisystem has implemented a $5.00 contribution for every person who shares their story on the American Diabetes Association’s Stop Diabetes website, up to $100,000 through December 31, 2009.

20 Nov 2009

SCF founder Sabrina Cohen recognized as a WebMD 2009 Health Hero

Sabrina Cohen, founder of The Sabrina Cohen Foundation for Stem Cell Research (SCF), was just recognized as a WebMD 2009 Health Hero. She will receive national media attention with a full-page article about her personal story of triumph and courage, and shares the spotlight with celebrity movie-star, Scarlett Johansson and other Health Heroes in the November/December issue.

20 Nov 2009

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.

20 Nov 2009

University of Michigan scientists discover how SEVI works

Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.

20 Nov 2009

I-STEM team succeeds in recreating a whole epidermis from hES cells

Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.

20 Nov 2009

New studies suggest elevated risk of gastrointestinal cancers in diabetic patients

There are minimal data assessing the relationship between diabetes with gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM).

20 Nov 2009

Diabetes News and Research

Latest Diabetes News and Research

Bio-Quant to be acquired by NexMed

Human Genome Sciences commences patient dosing in its HGS1029 inhibitor trial

Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement

Amniotic fluid stem cells have potential to become specialized cell types, say researchers

Study examines how dietary restriction and high-caloric diet influence biochemical responses

Pennsylvania Department of Health commences H1N1 vaccination to members of priority groups

Obesity: A major contributor to the development of Type 2 diabetes

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

Employers take action to improve medication adherence

PhRMA reaffirms its commitment to support the health reform

ESC and EASD organize Joint Scientific Forum in China to address optimal treatment strategies for diabetes

FDA approves sNDA for pediatric autism drug ABILIFY

First-quarter fiscal 2010 results announced by Escalon Medical

8.3% of households in Massachusetts struggle with food insecurity

Nutrisystem announces support for the Stop Diabetes movement

SCF founder Sabrina Cohen recognized as a WebMD 2009 Health Hero

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

University of Michigan scientists discover how SEVI works

I-STEM team succeeds in recreating a whole epidermis from hES cells

New studies suggest elevated risk of gastrointestinal cancers in diabetic patients

Genomics - Industry Focus eBook (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in